Green Cross, 162,724 Shares Net Sold by Individuals Over the Last 5 Days... Stock Price at 393,500 KRW (+2.21%)

Green Cross is trading at 393,500 KRW as of 12:31 PM on the 6th, up 2.21% from the previous day. The trading volume is 479,341 shares, which is 57.07% of the previous day's volume. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.

On November 3rd, researcher Lee Hye-rin from KTB Investment & Securities stated in a '3Q Earnings Preview' that although the results slightly missed the raised market expectations and their estimates, this was due to the postponement of flu/chickenpox vaccine export shipments (from September to October), resulting in a minor earnings adjustment. Typically, the third quarter, when domestic flu vaccine results are concentrated, shows a peak-out trend in both earnings momentum and stock price. However, with the COVID-19 vaccine CMO order momentum expected to emerge from year-end to early next year, further stock price increases are anticipated. Lee set Green Cross's target price at 390,000 KRW.

Over the past five days, individual investors have net sold 162,724 shares of Green Cross, while foreigners and institutions have net bought 62,306 shares and 157,661 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.